Clinical Trial Update: VISOR Versus PCNL for Treatment of 2-4cm Renal Stones [NA]

View source ↗

Summary

Clinical trial updating that VISOR versus PCNL for treating 2-4 cm renal stones is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Kidney Calculi, Kidney Stones | NA | Status: ENROLLING_BY_INVITATION